Mineralys Therapeutics, Inc. (MLYS) PT Raised to $52 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts MLYS Hot Sheet
Price: $25.64 -1.72%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Matthew Caufield raised the price target on Mineralys Therapeutics, Inc. (NASDAQ: MLYS) to $52.00 (from $42.00) while maintaining a Buy rating.
You May Also Be Interested In
- Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
- Mineralys Therapeutics, Inc. (MLYS) Misses Q2 EPS by 22c
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
